All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news


← First12345...825Next →

hiv & aids news selected from other sources

  • Young people
    UK Adolescents with Perinatally-Acquired HIV Are Not at Increased Risk of Anxiety, Depression
    MD Magazine | 15 hours ago

    Adolescents and Adults Living with Perinatal HIV (AALPHI) is an ongoing study in the United Kingdom that follows a cohort of young people with perinatally-acquired HIV (PHIV) and a control group of HIV-affected youth, who have a parent, sibling, or other household member living with HIV.

  • Women
    The Blesser's Curse
    The Atlantic | 23 hours ago

    How sugar daddies and vaginal microbes created the world’s largest HIV epidemic.

  • New and experimental HIV treatments
    ViiV Healthcare gains CHMP Positive Opinion for Juluca (dolutegravir/rilpivirine) in Europe
    ViiV press release | 23 hours ago

    The European Committee for Medicinal Products for Human Use (CHMP) has issued a Positive Opinion recommending marketing authorisation for Juluca (dolutegravir/rilpivirine) for the treatment of HIV infection in adults who are virologically suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor or integrase inhibitor.

  • Tuberculosis and HIV
    UNAIDS calls for bold action to end TB and AIDS
    UNAIDS | 23 March 2018

    Ahead of World TB Day 2018, UNAIDS is calling on all partners to take unprecedented and bold action to advance efforts to end tuberculosis (TB) and AIDS by 2030.

  • PrEP
    HIV drug Prep given to 390 people during Wales trial
    BBC | 23 March 2018

    The Welsh Government is funding a three-year trial, launched in July, of the daily pill Prep despite being recommended not to pay for the drug on cost-effectiveness grounds. Health Secretary Vaughan Gething said none of the 386 people given Prep so far had developed HIV.

  • Elimination of hepatitis C
    Eliminating Hepatitis C in England
    All-Party Parliamentary Group on Liver Health | 23 March 2018

    England will not fulfil its commitment to elimination of hepatitis C by 2030 unless the number of people diagnosed and initiated onto treatment is greatly increased.

  • Pharmaceutical industry
    Argentine NGO objects to antiretroviral patent request
    Sci Dev Net | 23 March 2018

    NGO requests rejection of Gilead Sciences patent request for TAF (Tenofovir Alafenamide fumarate). It alleges it would increase costs, says there is no basis for request.

  • People and personal stories
    Concerns About Robert Redfield for CDC
    Poz | 22 March 2018

    Nominated to head the Centers for Disease Control and Prevention, Dr. Redfield has close ties with anti-gay and anti-PLHIV activists.

  • Vaccines
    Better ways to combat HIV than seeking a vaccine
    Business Day | 22 March 2018

    Are human-vaccine trials the best use of resources? Based on the current reality, HIV treatment and prevention strategies that have been proven to work would be a much better use of the millions of dollars being spent on the large-scale vaccine clinical trials.

  • Elimination of hepatitis C
    Systematic Hep C Test-and-Treat Lowers Rate in Gay Men With HIV
    Poz | 22 March 2018

    A Swiss research program tested for and treated hep C in a large cohort of HIV-positive men who have sex with men over time.

← First12345...10Next →

Conference news

News from the annual Conference on Retroviruses and Opportunistic Infections (CROI 2018).

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Achieving the 90-90-90 target

With advances in HIV testing, treatment and care, some countries are making great progress towards the UNAIDS 90-90-90 target.

New EUROBulletin

Read the December edition of the Sexual Health & HIV Policy EUROBulletin.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.